Myriad Genetics Receives the Charles R. Smart Visionary Award

Myriad Genetics has announced that the Company is the honorable recipient of the 2012 Charles R. Smart Visionary Award from the American Cancer Society's Salt Lake City office, a part of the Great West Division.

This award is presented annually at the Society's Legacy & Leadership event to recognize organizations that have made extraordinary efforts in the fight against cancer.

Myriad and its employees are dedicated to saving lives and improving the quality of life of patients with cancer.

In addition to its life-saving molecular diagnostic tests, Myriad is a local community leader with the American Cancer Society in the fight against cancer.

The Company and its employees have played an important role in events to benefit the American Cancer Society including the Hope Gala, Making Strides Against Breast Cancer and Relay for Life.

"We are deeply honored to receive the Charles R. Smart Visionary award," said Peter Meldrum, President and Chief Executive Officer of Myriad Genetics.

Meldrum continued, "Myriad and the American Cancer Society share the goal of improving the quality of life for patients with cancer. Everyday our activities are guided by this mission and therefore we have been pleased to offer our financial support, leadership involvement and volunteer participation to this cause."

The late Dr. Charles R. Smart, a lifelong resident of Utah, was a pioneer in the study of cancer.

Dr. Smart spent more than 35 years focused on establishing computerized cancer research and was the founder of the Utah Cancer Registry, a population based registry that has been doing systematic cancer surveillance in the state since 1966.